SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle's stock is under pressure following earnings results that sparked concerns about heavy AI-related spending and its impact on future profitability; the community is closely watching key support levels. Some believe this is an overreaction and a buying opportunity, while others fear the company's debt and cash flow issues could continue to weigh on the stock. Chatter suggests a broader reassessment of AI-exposed companies is underway as investors digest the implications of Oracle's report.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending downwards as investors discuss customer losses and a recent analyst price cut, leading to concerns about its competitive position against larger platforms; the stock is nearing 52-week lows, sparking debates about potential takeover bids and whether it's a buying opportunity or a value trap given tax-loss selling pressures and potential Nasdaq 100 exclusion.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss its potential in treating cancers, particularly after positive data in prostate cancer trials, while also citing undervaluation. The community is actively discussing the possibility of a short squeeze given the high short interest. Some also speculate about potential partnerships and acquisitions in the near future! LOAD!

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

GEMI is trending due to its derivatives arm, Gemini Titan, securing a CFTC license to launch regulated prediction markets in the U.S., a move celebrated by CEO Tyler Winklevoss. Community chatter highlights the potential for a short squeeze and increased valuation, with some drawing comparisons to prediction market competitors. The license is viewed as a significant catalyst, potentially unlocking substantial growth amid the broader crypto adoption boom.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors anticipate its upcoming Autonomy and AI Day, with discussions focused on the company's technology roadmap and potential advancements in autonomous driving. The community is debating whether the event will be a catalyst for growth or a "sell the news" event, and there is also some skepticism related to competition in the EV sector and historical stock manipulation.

Black Titan Corp. was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. It intends to explore and identify viable business opportunities. The company was founded on July 11, 2024 and is headquartered in Petaling Jaya, Malaysia.

Black Titan Corp.

Black Titan Corp. is trending as community members discuss its recent surge following news of its strategic entry into digital assets. Traders are actively debating holding strategies amidst volatility, with some pointing to dilution concerns and potential short squeeze opportunities. The stock's low float and potential for further news related to its digital asset framework are also fueling interest.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending as traders anticipate news from an upcoming conference and potential operational updates, focusing on the company's shift towards AI infrastructure and efficient energy use. Community members are actively discussing price targets and potential short squeezes, citing the stock's low float and past volatility. This buzz comes after the company resolved a legal battle with its former CEO, which is now seen as a positive catalyst for its re-emergence.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as investors anticipate earnings, especially in light of potential AI chip deals with major tech companies like Microsoft. Community discussions revolve around whether Broadcom can deliver strong guidance and justify its valuation amidst broader concerns of an AI spending slowdown. Bullish sentiment is fueled by expectations of significant AI revenue growth and the company's history of exceeding estimates.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood ($HOOD) is trending amid discussions about its recent price action and correlation with crypto markets like Bitcoin, with some traders pointing to potential overbought conditions and profit-taking. Community members are also weighing in on the stock's long-term potential, the impact of news, and the potential implications of regulatory actions and expansion into new markets. The stock's performance is being actively compared to competitors like SoFi.

AXIL Brands, Inc. engages in the manufacture, market, sale and distribution of hearing and audio enhancement, and protection products. It operates through the Hearing Enhancement and Protection, and Hair Care and Skin Care segments. The Hearing Enhancement and Protection segment includes ear buds, earmuffs, ear plugs, outdoor speakers, and ear care items. The Hair Care and Skin Care segment focuses on expanding its business-to-business salon sales through its network of domestic and international distributors. The company was founded on May 21, 2015 and is headquartered in Beverly Hills, CA.

AXIL Brands Inc.

AXIL Brands is trending as traders discuss its distribution agreement with Walmart, which led to significant pre-market gains and a surge in volume. Community chatter revolves around whether the stock can sustain its momentum and break past resistance levels, with some anticipating a potential short squeeze, while others express skepticism and caution against chasing the rally. Discussions also involve comparisons to other companies in the hearing enhancement industry and speculation about institutional interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETF Fundamental Report for ITOT

Below is Validea's ETF fundamental report for iShares Core S&P Total U.S. Stock Market ETF (ITOT). The report looks at ITOT's exposure to the major investing factors including value, quality...

ETFs to Keep Your Portfolio on Track in the Long Term

Despite November's volatility, optimism is returning to Wall Street. Discover how long-term strategies combined with ETFs can help investors build resilient portfolios ready to capture the next phase of the bull market.

ITOT ETF Factor Report

Buffett's Investing Lessons: What They Mean for ETF Investors

Buffett's final lessons guide ETF investors toward discipline, cash strength and quality picks like SPY, ITOT, VTV and MINT.

<ul class="summary-bullets"><li>USA Rare Earth said that the acquisition represents a significant acceleration of its magnet-to-mine strategy, establishing an end-to-end rare earth supply chain.&nbsp;</li><li>The deal would enable LCM to continue expanding and serving its global customer base with a broad portfolio of rare earth and critical metals and alloys.</li><li>The deal comes on the heels of the Trump administration’s attempt to boost U.S. production of critical minerals and the government has invested in a few rare earth companies, including MP Materials and Trilogy Metals.</li></ul>USA Rare Earth (USAR) shares rose nearly 3% in premarket trading on Wednesday after the company announced that it had received regulatory approval from the UK Minister of State for its acquisition of LCM.The company said that it has now received the only regulatory approval required and expects to close the acquisition on time, in line with its target for the fourth quarter of calendar year 2025.<h2 class="st-heading-2">Rare Earth Push In The US</h2>The deal comes on the heels of the Trump administration’s attempt to boost U.S. production of critical minerals, and the government has invested in a few rare earth companies, including MP Materials and Trilogy Metals.The U.S. and China have also reached an agreement to ease rare-earth exports for at least a year. According to a White House Memo, China will issue general licenses valid for the export of rare earths, gallium, germanium, antimony, and graphite, benefiting U.S. end-users and their suppliers worldwide.The general license means the de facto removal of controls China imposed since 2023.<h2 class="st-heading-2">USA Rare Earth, LCM Deal</h2>USA Rare Earth said that the acquisition represents a significant acceleration of its magnet-to-mine strategy, establishing an end-to-end rare earth supply chain. The deal would enable LCM to continue expanding and serving its global customer base with a broad portfolio of rare earth and critical metals and alloys.This would also help in the supply of Neodymium Iron Boron (NdFeB) metal and strip cast alloy to USAR's Stillwater, Oklahoma magnet facility once production begins.USA Rare Earth said that LCM's metals and alloys are essential to the manufacturing of advanced magnets, semiconductors, and aerospace components. LCM supplies customers across defense, automotive, electric vehicle, industrial, and technology sectors in the U.S., UK, France, Germany, Japan, and Taiwan.Retail sentiment on USA Rare Earth remained unchanged in the ‘bearish’ territory, with message volumes at ‘low’ levels, according to data from Stocktwits.<a href="https://stocktwits.com/symbol/USAR">Shares of USA Rare Earth</a> have gained nearly 55% this year and increased by 65% over the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/google-sues-global-cybercrime-ring-over-massive-smishing-campaign-report/cLPIu1eRE5Y">Google Sues Global Cybercrime Ring Over Massive Smishing Campaign: Report</a>

In this photo illustration, the USA Rare Earth logo is seen displayed on a smartphone screen.

USA Rare Earth Stock Rises After Clearing Final Regulatory Hurdle In LCM Acquisition

The company has announced that it has now received the only regulatory approval required and expects to close the acquisition on schedule, in line with its stated target for the fourth quarter of calendar year 2025.

Equity

The company has announced that it has now received the only regulatory approval required and expects to close the acquisition on schedule, in line with its stated target for the fourth quarter of calendar year 2025.


<ul class="summary-bullets"><li>Ondas said that Sentry CS has seen rapid growth, with combat-proven deployments across 25 countries, and has achieved fully operational threat mitigation.</li><li>The company expects the transaction to close in November 2025, and the terms of the deal have not been disclosed.</li><li>Last week, Ondas announced a definitive agreement to acquire a controlling interest in 4M Defense, an Israeli smart demining company specializing in advanced demining capabilities.</li></ul>Ondas Holdings Inc. (ONDS) became one of the top trending tickers on Stocktwits and the company’s shares rose 4% in early trading on Tuesday following the announcement that it has entered into a definitive agreement to acquire Sentry CS, an Israel-based company in Cyber-over-RF (CoRF) and Protocol-Manipulation counter-Unmanned Aerial Systems (UAS) technology."The addition of Sentrycs will strengthen our leadership in counter-UAS and solidify Ondas' position as a full-spectrum provider of autonomous defense solutions," said Eric Brock, Chairman and CEO of Ondas Holdings.&nbsp;Ondas expects the transaction to close in November 2025. The terms of the deal were not disclosed.Retail sentiment on Ondas jumped to ‘bullish’ from ‘bearish’ territory compared to a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.<h2 class="st-heading-2">Sentry CS’ Technology</h2>Ondas said that Sentry CS has seen rapid growth, with combat-proven deployments across 25 countries, and has achieved fully operational threat mitigation."Passive RF detection and tracking are essential to modern layered defense, and Sentrycs brings a proven technology platform already deployed across sensitive airspace, critical infrastructure, and border environments,” Brock said.Brock added that by integrating Sentry CS with Ondas’ Iron Drone Raider system, the company expects to deliver a unified detect-to-defeat solution that addresses the rapidly evolving threat landscape for its defense and homeland security customers worldwide.<h2 class="st-heading-2">Ondas’ Recent Slew Of Acquisitions</h2>Last week, Ondas announced a definitive agreement to acquire a controlling interest in 4M Defense, an Israeli smart demining company specializing in advanced demining capabilities, including robotic systems with terrestrial and subsurface AI-powered intelligence technologies.Ondas had noted that 4M Defense will expand Ondas Autonomous Systems’ addressable market into the large global landmine and UXOs clearance and subsurface intelligence platforms market.The company had also announced the acquisition of a controlling interest in Insight Intelligent Sensors, an Israeli developer of AI-driven electro-optical sensing systems.<a href="https://stocktwits.com/symbol/ONDS">Shares of Ondas</a> have gained over 771% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dennys-620-million-deal-oppenheimer-says-not-expecting-competitive-bidding-process/cL28guSR36a">Denny's $620 Million Deal: Oppenheimer Says Not Expecting ‘Competitive Bidding Process’</a>

In this photo illustration, a person holds a smartphone displaying the logo of Ondas Holdings Inc. 

ONDS Stock Rises Following Acquisition Of Israel-Based Sentry CS

Ondas expects the transaction to close in November 2025, and the terms of the deal have not been disclosed.

<ul class="summary-bullets"><li>The payment was in connection with the dosing of the first patient in a late-stage registrational trial of Ziftomenib.</li><li>Kura Oncology and Kyowa Kirin had entered into a deal in November 2024 to jointly develop and commercialize Ziftomenib. &nbsp;</li></ul>Kura Oncology (KURA) said on Friday that it received a $30 million milestone payment under its collaboration agreement with Japan-based Kyowa Kirin, inked late last year.The <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/24/3172720/35186/en/Kura-Oncology-Receives-30-Million-Development-Milestone-Payment-in-Ziftomenib-AML-Program-with-Kyowa-Kirin.html">payment</a> was in connection with the dosing of the first patient in a late-stage registrational program of Ziftomenib evaluating the drug in combination with both intensive and non-intensive chemotherapy regimens in patients with newly diagnosed acute myeloid leukemia with certain conditions. The companies announced the launch of the said trial on September 29.The program includes two late-stage trials intended to support potential U.S. accelerated approval and full approval. The trial is expected to enroll patients at up to 200 sites worldwide.According to Kura, the late-stage program is the only menin inhibitor program actively pursuing registrational trials across both intensive and non-intensive chemotherapy settings.<h2 class="st-heading-2">Terms Of The Deal</h2>Kura Oncology and Kyowa Kirin had entered into a deal in November 2024 to jointly develop and commercialize Ziftomenib. Under the agreement, Kura is eligible to receive up to $1.2 billion in total milestone payments, including near-term milestone payments. &nbsp;As per the terms of the agreement, Kura will lead development, regulatory, and commercial strategy in the U.S. while Kyowa leads it outside the U.S.<a href="https://stocktwits.com/symbol/KURA">KURA shares</a> traded 6% higher in the pre-market session at the time of writing. On Stocktwits, retail sentiment around KURA stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.KURA stock is up by over 4% this year but down by about 49% over the past 12 months.Read also:<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/jp-morgan-to-let-clients-use-bitcoin-ethereum-as-loan-collateral-by-year-end/cLGJVtKR3sH"> JPMorgan To Let Clients Use Bitcoin, Ethereum As Loan Collateral By Year-End: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

KURA Stock Rises Pre-Market After Receiving Milestone Payment Related To Cancer Drug Development Agreement

The payment was in connection with the dosing of the first patient in a late-stage registrational trial of Ziftomenib.

<ul class="summary-bullets"><li>Viking on Thursday reported a third-quarter loss per share of $0.81, compared to the expected loss of $0.7 per share.&nbsp;</li><li>Morgan Stanley raised its price target on VKTX to $102 from $98 while maintaining an ‘Overweight’ rating.</li><li>The analyst noted that two of the company’s late-stage trials for subcutaneous VK2735 are enrolling ahead of schedule.</li></ul>Viking Therapeutics (VKTX) received a price target hike from Morgan Stanley on Thursday on the heels of positive third-quarter updates.&nbsp;Morgan Stanley raised its price target on VKTX to $102 from $98 while maintaining an ‘Overweight’ rating. The new price target represents a potential upside of 225% from the stock’s closing price on Wednesday.<h2 class="st-heading-2">Morgan Stanley’s Take</h2>The analyst noted that two of the company’s late-stage trials for subcutaneous VK2735 are enrolling ahead of schedule, and the management plans to meet with the U.S. Food and Drug Administration for oral VK2735 in Q4 with a late-stage study start targeted soon after. The firm is "encouraged by swift execution across programs," the analyst added.Viking CEO Brian Lian said on Thursday that the company is expected to complete enrollment in the VANQUISH-1 study later this quarter, with VANQUISH-2 to follow in the first quarter of 2026. The VANQUISH late-stage program, including trials of Viking's subcutaneous formulation of VK2735 in patients with obesity and obesity with type 2 diabetes, was initiated in the second quarter.Viking on Thursday <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/viking-therapeutics-reports-third-quarter-2025-financial-results-and-provides-corporate-update-302591893.html">reported</a> a third-quarter loss per share of $0.81, compared to the expected loss of $0.7 per share, according to data from Fiscal AI. The company pinned the rise in net loss for the three months ended Sept. 30, 2025, to the increase in research and development expenses.The company ended the quarter with a cash position of $715 million, which it believes provides sufficient resources to develop VK2735 through the VANQUISH clinical trials and to continue development of additional clinical programs in its pipeline.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2><a href="https://stocktwits.com/symbol/VKTX">VKTX shares</a> soared 7% at the time of writing. On Stocktwits, retail sentiment around VKTX jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘high’ levels. Retail chatter around the stock rose 197% over the past 24 hours, as of Thursday morning, according to Stocktwits data.<figure class="image"><img style="aspect-ratio:620/63;" src="data:image/png;base64,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" width="620" height="63" alt="VKTX's Sentiment Meter and Message Volume as of 10:06 a.m. ET on Oct. 23, 2025 | Source: Stocktwits"><figcaption>VKTX's Sentiment Meter and Message Volume as of 10:06 a.m. ET on Oct. 23, 2025 | Source: Stocktwits</figcaption></figure>VKTX stock is down by 16% this year and by 44% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/harmony-biosciences-raises-full-year-revenue-guidance-ahead-of-earnings/cLG4ilnR3rG">Harmony Biosciences Raises Full-Year Revenue Guidance Ahead Of Earnings: Why Are Wakix Franchise Numbers Crucial?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of Viking Therapeutics, Inc., in front of a screen showing the company's latest stock market chart on July 19, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside

Morgan Stanley raised its price target on VKTX to $102 from $98 while maintaining an ‘Overweight’ rating.

BlackRock Institutional Trust Company N.A. - iShares Core S&P Total U.S. Stock Market ETF

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

Current Price	$150.19
Prev Close	$150.31
Open	$149.79
Dividend Yield	N/A
50-Day Moving Average	$147.14
Beta	N/A
Avg. Volume	3.72M
PE Ratio	N/A

52-Week High	$150.70
52-Week Low	$105.00
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

ITOT
iShares Core S&P Total U.S. Stock Market ETF

Feed

News

Sentiment

Fundamentals

Info

Latest ITOT News

ITOTiShares Core S&P Total U.S. Stock Market ETF